MODERATE TO SEVERE GLABELLAR LINES
Clinical trials for MODERATE TO SEVERE GLABELLAR LINES explained in plain language.
Never miss a new study
Get alerted when new MODERATE TO SEVERE GLABELLAR LINES trials appear
Sign up with your email to follow new studies for MODERATE TO SEVERE GLABELLAR LINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New wrinkle injection shows promise in phase 3 trial
Symptom relief Recruiting nowThis study tests a single injection of IPN10200, a botulinum toxin type A, to improve moderate to severe frown lines between the eyebrows. About 300 adults will receive either the active drug or a placebo. Researchers will check how well the lines improve over 52 weeks using doct…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New wrinkle treatment aims to smooth frown lines in large trial
Symptom relief Recruiting nowThis phase 3 study tests an injection called IPN10200 for moderate to severe frown lines (the wrinkles between your eyebrows). About 1,300 adults will receive either the active treatment or a placebo, and some may get up to 4 treatment cycles over nearly two years. The goal is to…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Jun 27, 2026 12:26 UTC
-
New wrinkle treatment eveotox takes on botox in major trial
Symptom relief Recruiting nowThis phase 3 study tests a new injection called Eveotox, made from a lab-grown version of botulinum toxin, against Botox and a placebo for moderate to severe frown lines. About 669 adults aged 18 to 65 will receive one or more treatments. Researchers will check how well it smooth…
Matched conditions: MODERATE TO SEVERE GLABELLAR LINES
Phase: PHASE3 • Sponsor: JHM BioPharma (Tonghua) Co. , Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 12:49 UTC